Wird geladen...
Dofetilide Initiation and Implications of Deviation From the Standard Protocol – A Real World Experience
BACKGROUND: Manufacturer/federal drug administration (FDA) recommends inpatient initiation of dofetilide with the manufacturer providing an initiation algorithm. The outcomes of algorithm deviation have not been reported outside of clinical trials. OBJECTIVE: We sought to perform a chart review of a...
Gespeichert in:
| Veröffentlicht in: | J Atr Fibrillation |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cardiofront, Inc
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7237080/ https://ncbi.nlm.nih.gov/pubmed/32435348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.2265 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|